ArticleJournal of neuro-oncology2025
Utility and performance of cerebrospinal fluid cytology in discriminating central nervous system infections and brain tumors.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrative Analysis of Clinical Features and Cerebrospinal Fluid Immune Microenvironment in Leptomeningeal Metastasis From Non-small-cell Lung Cancer Patients.Clinical Medicine Insights. Oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
objectiveDifferentiating central nervous system infections (CNSIs) from brain tumors (BTs) is difficult due to overlapping features and the limited individual indicators, and cerebrospinal fluid (CSF) cytology remains underutilized. To improve differential diagnosis, we developed a model based on 9 early, cost-effective cerebrospinal fluid parameters, including CSF cytology.
methodsPatients diagnosed with CNSIs or BTs at Xiangya Hospital of Central South University between October 1st, 2017 and March 31st, 2024 were enrolled and divided into the training set and the test set. Lasso analysis, random forest, and multivariable logistic regression were used to construct a diagnostic model to distinguish CNSIs from BTs by utilizing differences in basic CSF parameters and CSF cytology results. And its diagnostic efficacy was evaluated using the receiver operating characteristic (ROC) curve. A nomogram was used for model visualization.
resultsA total of 783 patients were included in this study. 9 important CSF parameters significantly contribute to the differentiation between CNSIs and BTs, including CSF pressure, protein, glucose, adenosine deaminase, chloride, and the counts of lymphocytes, monocytes, plasma cells and phagocytes. CSF phagocytes and monocytes were elevated in BTs, whereas lymphocytes and plasma cells were higher in CNSIs. The model demonstrated strong diagnostic performance, achieving an area under the ROC curve (AUC) of 0.889 in the training set and 0.900 in the test set.
conclusionsWe developed a diagnostic model based on 9 CSF indicators. In our study, CSF phagocytes and monocytes were associated with BTs, while lymphocytes and plasma cells indicated CNSIs.
Indexed as
Identifiers
40928611What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.